Cargando…
The mitochondrial inhibitor IF1 binds to the ATP synthase OSCP subunit and protects cancer cells from apoptosis
The mitochondrial protein IF1 binds to the catalytic domain of the ATP synthase and inhibits ATP hydrolysis in ischemic tissues. Moreover, IF1 is overexpressed in many tumors and has been shown to act as a pro-oncogenic protein, although its mechanism of action is still debated. Here, we show that A...
Autores principales: | Galber, Chiara, Fabbian, Simone, Gatto, Cristina, Grandi, Martina, Carissimi, Stefania, Acosta, Manuel Jesus, Sgarbi, Gianluca, Tiso, Natascia, Argenton, Francesco, Solaini, Giancarlo, Baracca, Alessandra, Bellanda, Massimo, Giorgio, Valentina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870916/ https://www.ncbi.nlm.nih.gov/pubmed/36690622 http://dx.doi.org/10.1038/s41419-023-05572-y |
Ejemplares similares
-
The ATP Synthase Deficiency in Human Diseases
por: Galber, Chiara, et al.
Publicado: (2021) -
Deregulation of mitochondrial F1FO-ATP synthase via OSCP in Alzheimer’s disease
por: Beck, Simon J., et al.
Publicado: (2016) -
The F1Fo-ATPase inhibitor protein IF1 in pathophysiology
por: Gatto, Cristina, et al.
Publicado: (2022) -
Hypoxia and IF(1) Expression Promote ROS Decrease in Cancer Cells
por: Sgarbi, Gianluca, et al.
Publicado: (2018) -
Mitochondrial Mass Assessment in a Selected Cell Line under Different Metabolic Conditions
por: Costanzini, Anna, et al.
Publicado: (2019)